Michael David Garrison
EVP & Pres Med.Essntl&BioPharm · 3 filings · Latest: Jun 24, 2026
BECTON DICKINSON & CO
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BDX | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Jun 24, 2026 | Sale | $145.66 | 1,100 | $160.2K | 13,172 | |
BDX | MICHAEL GARRISON | — | Jun 24, 2026 | Proposed Sale | $143.92 | 1,100 | $158.3K | — | |
BDX | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Jun 10, 2026 | Sale | $151.48 | 1,100 | $166.6K | 14,272 | |
BDX | MICHAEL GARRISON | — | Jun 10, 2026 | Proposed Sale | $152.04 | 1,100 | $167.2K | — | |
BDX | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Jan 15, 2026 | Sale | $207.46 | 1,610 | $334.0K | 12,095 | |
BDX | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Jan 15, 2026 | Option Exercise | $167.91 | 3,054 | $512.8K | 16,159 | |
BDX | MICHAEL GARRISON | — | Jan 15, 2026 | Proposed Sale | $207.42 | 1,610 | $333.9K | — | |
BDX | MICHAEL GARRISON | — | Dec 17, 2025 | Proposed Sale | $196.39 | 629 | $123.5K | — | |
BDX | MICHAEL GARRISON | — | Jul 18, 2025 | Proposed Sale | $180.90 | 1,185 | $214.4K | — | |
BDX | MICHAEL GARRISON | — | Apr 9, 2025 | Proposed Sale | $200.83 | 479 | $96.2K | — | |
BDX | MICHAEL GARRISON | — | Jan 17, 2025 | Proposed Sale | $236.30 | 597 | $141.1K | — | |
BDX | MICHAEL GARRISON | — | Dec 19, 2024 | Proposed Sale | $224.09 | 2,838 | $636.0K | — |